Drug intelligence / Profile preview

Lactobiogen

Development stage: Unknown
Lead developer: Laves-Arzneimittel
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactobiogen is a probiotic dietary supplement developed by Laves-Arzneimittel GmbH to support intestinal health and the immune system. It contains a concentrated blend of four specific lactic acid-producing bacterial strains: *Bifidobacterium lactis* BB-12, *Lactobacillus acidophilus* LA-5, *Lactobacillus delbrueckii subsp. bulgaricus* LBY-27, and *Streptococcus thermophilus* STY-31. These strains are delivered in a capsule form designed to survive stomach acid and colonize the intestinal tract. The product is primarily used to restore natural intestinal flora, particularly following antibiotic treatment, and to maintain overall digestive and immune function. It is free from common allergens such as lactose, gluten, and soy, and contains no animal-derived ingredients.

Brand names: Lactobiogen

Beyond the preview

Go deeper on Lactobiogen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobiogen.

Explore the full profile